Chem. J. Chinese Universities ›› 2020, Vol. 41 ›› Issue (3): 481.doi: 10.7503/cjcu20190446

• Organic Chemistry • Previous Articles     Next Articles

Synthesis and Antitumor Activities of α-2,7,11-Cembratriene-4,6-diol Derivatives

BAI Bing,WANG Long,XU Gaigai,YANG Pengfei,ZHANG Gaihong,MAO Duobin   

  1. School of Food & Biological Engineering, Zhengzhou University of Light Industry, Zhengzhou 450000, China
  • Received:2019-08-09 Online:2020-02-26 Published:2019-12-31
  • Contact: Duobin MAO
  • Supported by:
    † Supported by the National Natural Science Foundation of China(No.21476216);the Key Laboratory Foundation of National Tobacco Monopdy Bureau, China(No.[2014]334)

Abstract:

Twenty eight α-2,7,11-cembratriene-4,6-diol derivatives were prepared by the modification at C6 position via introduction of acyl and ether groups. Their structures were confirmed by nuclear magnetic resonance spectroscopy(NMR) and high resolution mass spectrometry(HRMS). The synthesized compounds were screened for their in vitro biological activity. The results of 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfopheny)-2H-tetrazolium(MTS) assay indicated that some of them showed the same anticancer activity as cisplatin(DDP) did. Among them, α-2,7,11-cembratriene-4-ol-6-phenylacetate(1i) showed cytotoxicity against MCF-7 with an IC50 value of 15.45 μmol/L, and α-2,7,11-cembratriene-4-ol-6-(2-F)phenylacetate(1t) showed cytotoxicity against SMMC-7721 with an IC50 value of 11.44 μmol/L, respectively. Structure-activity relationship revealed that the phenylacetate substituents at C6 position played an important role in inhibition activity.

Key words: Cembratriene derivative, Antitumor, Tobacco

CLC Number: 

TrendMD: